Capital Fund Management (CFM)
UTHR icon

Capital Fund Management (CFM)’s United Therapeutics UTHR Stock Holding History

Capital Fund Management (CFM)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,100
Closed -$798K – 2291
2018
Q1 		$798K Buy
+7,100
New +$902K ﹤0.01% 1307

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capital Fund Management (CFM)'s UTHR Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its United Therapeutics (UTHR) stake by 8.3% in Q2 2026, buying an estimated $2.29M and bringing the position to 53,037 shares worth $28.7M. The position accounts for 0.13% of the portfolio, ranked #190.

Capital Fund Management (CFM) first reported a position in UTHR in Q2 2013 and has held it in 32 quarters since. The position peaked at $29M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Capital Fund Management (CFM) held 53,037 shares of United Therapeutics worth $28.7M as of Q2 2026.
  • Capital Fund Management (CFM) bought 4,073 United Therapeutics shares in Q2 2026, an estimated $2.29M.
  • United Therapeutics made up 0.13% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #190 holding.
  • Capital Fund Management (CFM) first reported a position in United Therapeutics in Q2 2013 and has held it in 32 quarters since.
  • Capital Fund Management (CFM)'s United Therapeutics position peaked at $29M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.